# Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors

> **NCT00058253** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 80 (actual)

## Conditions studied

- Recurrent Prostate Cancer
- Stage IV Prostate Cancer
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** tanespimycin
- **DRUG:** docetaxel

## Key facts

- **NCT ID:** NCT00058253
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** 2008-01
- **Final completion:** 2010-03
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2014-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00058253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00058253, "Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00058253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*